Lymphoma & Plasma Cell Disorders
News
FDA warns of possible link between breast implants and ALCL
People with breast implants “may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant,” according to the...
Video
Brentuximab and Refractory Hodgkin's Lymphoma
News
Denileukin diftitox has significant, durable responses in CTCL
The recombinant fusion protein denileukin diftitox (DD) produced a significant and durable overall response rate at 2 dose levels as compared to...
News
ODAC votes against one leukemia, one NHL drug
News
Phase 3 trial of pixantrone leaves FDA uneasy
The drug is intended to treat non-Hodgkin’s lymphoma (NHL) that has resisted at least 2 other treatments. Among multiple concerns, the trial only...
Video
First-Line Lymphoma Treatments
Video
Multiple Myeloma in the Elderly
News
Fostamatinib successfully targets the B-cell receptor
The B-cell receptor is present on both normal B cells and malignant B cells. Signaling through this receptor is necessary for B-cell maturation...
News
Panobinostat shows promise in refractory Hodgkin lymphoma
New York, NY —Growing evidence suggests that the potent pan-deacetylase inhibitor panobinostat (LBH589) shows promising clinical activity in...
News
Ofatumumab receives accelerated approval from FDA
The drug was approved under the FDA’s accelerated approval process, which allows drugs that meet unmet medical needs to be approved faster.